MATRICARDI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 2.744
AS - Asia 2.150
EU - Europa 1.124
SA - Sud America 410
Continente sconosciuto - Info sul continente non disponibili 303
AF - Africa 46
OC - Oceania 4
Totale 6.781
Nazione #
US - Stati Uniti d'America 2.648
SG - Singapore 984
CN - Cina 612
BR - Brasile 331
RU - Federazione Russa 283
IT - Italia 279
VN - Vietnam 242
IE - Irlanda 195
GB - Regno Unito 76
HK - Hong Kong 58
DE - Germania 55
UA - Ucraina 55
CA - Canada 54
BD - Bangladesh 53
TR - Turchia 49
IN - India 38
FR - Francia 33
MX - Messico 31
SE - Svezia 30
AR - Argentina 27
PL - Polonia 26
EC - Ecuador 20
FI - Finlandia 20
KR - Corea 20
NL - Olanda 19
ZA - Sudafrica 18
ID - Indonesia 16
JP - Giappone 16
CO - Colombia 15
AT - Austria 14
KE - Kenya 9
ES - Italia 8
LT - Lituania 8
MY - Malesia 7
TN - Tunisia 7
UZ - Uzbekistan 7
VE - Venezuela 7
PH - Filippine 6
PK - Pakistan 6
RO - Romania 6
SA - Arabia Saudita 6
IQ - Iraq 5
MA - Marocco 5
AU - Australia 4
BE - Belgio 4
IL - Israele 4
AE - Emirati Arabi Uniti 3
CZ - Repubblica Ceca 3
JO - Giordania 3
NP - Nepal 3
PY - Paraguay 3
BB - Barbados 2
CH - Svizzera 2
CL - Cile 2
EG - Egitto 2
JM - Giamaica 2
KG - Kirghizistan 2
MG - Madagascar 2
NI - Nicaragua 2
PE - Perù 2
PS - Palestinian Territory 2
QA - Qatar 2
YE - Yemen 2
AG - Antigua e Barbuda 1
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GF - Guiana Francese 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
KN - Saint Kitts e Nevis 1
KZ - Kazakistan 1
PR - Porto Rico 1
PT - Portogallo 1
SC - Seychelles 1
ST - Sao Tome e Principe 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UY - Uruguay 1
Totale 6.479
Città #
Singapore 700
San Jose 496
Council Bluffs 263
Ashburn 253
Dublin 195
Beijing 166
Dallas 137
Santa Clara 120
Los Angeles 113
The Dalles 87
Ho Chi Minh City 86
Hefei 73
Tongling 70
Hanoi 61
Columbus 60
Hong Kong 54
Jacksonville 54
New York 45
Redondo Beach 42
Phoenix 36
Buffalo 32
São Paulo 31
Seattle 29
Boardman 27
Pescara 27
Chieti 26
Moscow 25
St Louis 25
Chandler 24
Southend 24
Orem 23
Warsaw 23
Milan 20
Seoul 20
Princeton 19
Washington 19
London 17
Izmir 16
Nanjing 15
Nuremberg 15
San Francisco 15
Toronto 15
Atlanta 14
Denver 14
Lanciano 14
Mexico City 14
Chicago 13
Brooklyn 12
Haiphong 12
Da Nang 11
Romola 11
Cambridge 10
Dearborn 10
Frankfurt am Main 10
Rio de Janeiro 10
Rome 10
Altamura 9
Ann Arbor 9
Belo Horizonte 9
Johannesburg 9
Memphis 9
Montreal 9
Quito 9
Stockholm 9
Amsterdam 8
Shanghai 8
Tokyo 8
Chennai 7
Houston 7
Iesi 7
Lappeenranta 7
Manchester 7
Nanchang 7
Poplar 7
Porto Alegre 7
Vienna 7
Wilmington 7
Xi'an 7
Boston 6
Buenos Aires 6
Campobasso 6
Guayaquil 6
Hangzhou 6
Nairobi 6
Paris 6
Ankara 5
Biên Hòa 5
Brasília 5
Bắc Ninh 5
Catania 5
Dhaka 5
Guangzhou 5
Ipatinga 5
Pune 5
Shenzhen 5
Tianjin 5
Tunis 5
Bogotá 4
Brussels 4
Campinas 4
Totale 4.050
Nome #
Discovering a familial Xp11.4 microduplication: Does the mother matter? 166
Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access Program 128
Benign epilepsy of childhood with centro-temporal spikes (BECTS) versus migraine: a neuropsychological assessment 124
Neuropsychological impairment in children with Rolandic epilepsy and in their siblings. 114
A nationwide study on Sydenham's chorea: Clinical features, treatment and prognostic factors 111
Bone metabolism and vitamin D levels in carbamazepine-treated patients. 110
Topiramate: effects on serum lipids and lipoproteins levels in children 108
A profile of azetukalner for the treatment of epilepsy: from pharmacology to potential for therapy 106
Neuropsychological Symptoms and Quality of Life during the COVID-19 Pandemic in Children: A Survey in a Pediatric Population in the Abruzzo Region, Italy 103
Antiepileptic drugs and visual function. 103
Clinical and electroencephalographic features of epilepsy in patients with triple X syndrome: A case series 101
Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review 98
Neuroendocrine Effects on the Risk of Metabolic Syndrome in Children 97
The latest advances in the pharmacological management of focal epilepsies in children: a narrative review 95
Anti-seizure medications for Lennox-Gastaut syndrome 93
Perampanel as only add-on epilepsy treatment in elderly: A subgroup analysis of real-world data from retrospective, multicenter, observational study 90
Potential role of brivaracetam in pediatric epilepsy 90
Bi-allelic genetic variants in the translational GTPases GTPBP1 and GTPBP2 cause a distinct identical neurodevelopmental syndrome 90
Exploring the Landscape of Pre- and Post-Synaptic Pediatric Disorders with Epilepsy: A Narrative Review on Molecular Mechanisms Involved 89
A registry for Dravet syndrome: The Italian experience 88
Migralepsy and related conditions: advances in pathophysiology and classification. 87
Hemispherotomy in Rasmussen encephalitis: long-term outcome in an Italian series of 16 patients 86
An Italian consensus on the management of Lennox-Gastaut syndrome 84
Reflex myoclonic epilepsy in infancy: A multicenter clinical study 83
An unusual behavioural and motor paroxysmal disorder caused by insulinoma-related hypoglycemia: a possible cause of epilepsy misdiagnosis 81
Clinical dissection of childhood occipital epilepsy of Gastaut and prognostic implication 80
Genotype-phenotype correlation in contactin-associated protein-like 2 (CNTNAP-2) developmental disorder 79
The Cognitive and Behavioural Effects of Perampanel in Children with Neurodevelopmental Disorders: A Systematic Review 79
CDKL5 deficiency-related neurodevelopmental disorders: a multi-center cohort study in Italy 78
Clinical manifestations in children and adolescents with corpus callosum abnormalities 77
Neonatal developmental and epileptic encephalopathy due to autosomal recessive variants in SLC13A5 gene 77
Brivaracetam add-on treatment in pediatric patients with severe drug-resistant epilepsy: Italian real-world evidence 76
Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study 75
Memory impairment and Benign Epilepsy with centrotemporal spike (BECTS): a growing suspicion 74
The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies 74
Clinical and Molecular Characteristics of SLC16A2 (MCT8) Mutations in Three Families with the Allan-Herndon-Dudley Syndrome 74
Polysomnographic Findings in Fragile X Syndrome Children with EEG Abnormalities 74
Gain of function SCN1A disease-causing variants: Expanding the phenotypic spectrum and functional studies guiding the choice of effective antiseizure medication 73
Cognitive and neuropsychological evolution in children with anti-NMDAR encephalitis 73
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD 71
Erratum to: Long-term outcome of epilepsy in patients with prader–willi syndrome 71
Perisylvian, including insular, childhood epilepsy: Presurgical workup and surgical outcome 69
Withdrawal seizures: possible risk factors 69
First reported case of an inherited PACS2 pathogenic variant with variable expression 68
Palliative non-resective surgery for drug-resistant epilepsy 68
Pharmacotherapy for Dravet Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials 67
Current advances in childhood absence epilepsy 66
Epilepsy in Menkes disease: an electroclinical long-term study of 28 patients 66
Transition into adulthood: tuberous sclerosis complex, Sturge-Weber syndrome, and Rasmussen encephalitis 66
Rufinamide for the treatment of refractory epilepsy secondary to neuronal migration disorders 66
Epilepsy, electroclinical features, and long-term outcomes in Pitt-Hopkins syndrome due to pathogenic variants in the TCF4 gene 66
Focal seizure, focal dyskinesia, or both? A complex motor phenomenon reveals anti-NMDAR encephalitis 65
Gelastic seizures not associated with hypothalamic hamartoma: A long-term follow-up study 65
Trends in pediatric epilepsy surgery in Europe between 2008 and 2015: Country-, center-, and age-specific variation 65
Efficacy and Safety of Fenfluramine in Epilepsy: A Systematic Review and Meta-analysis 65
Symptomatic and presumed symptomatic focal epilepsies in childhood: An observational, prospective multicentre study 64
Pediatric NMDAR encephalitis: A single center observation study with a closer look at movement disorders 63
Unraveling the enigma of new-onset refractory status epilepticus: a systematic review of aetiologies 63
Electroclinical features of epilepsy in patients with InvDup(15) 62
Sleep disorders and neuropsychiatric disorders in a pediatric sample of tuberous sclerosis complex: a questionnaire-based study 62
Refractory absence seizures: An Italian multicenter retrospective study 62
Effectiveness of Perampanel as the Only Add-on: Retrospective, Multicenter, Observational Real Life Study on epilepsy patients 62
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study 62
Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications 61
Perampanel Monotherapy for Focal and Generalized Epilepsy in Clinical Practice 61
Perampanel tolerability in children and adolescents with focal epilepsy: Effects on behavior and executive functions 60
Monitoring And Managing Depression In Adolescents With Epilepsy: Current Perspectives 60
Neuropsychological profiles and outcomes in children with new onset frontal lobe epilepsy 59
Long-term effectiveness of add-on perampanel in patients with Lennox-Gastaut syndrome: A multicenter retrospective study 59
Epilepsy in the setting of full trisomy 18: A multicenter study on 18 affected children with and without structural brain abnormalities 58
Questionnaire-based assessment of sleep disorders in an adult population of Tuberous Sclerosis Complex 57
Social cognition and executive functions in children and adolescents with focal epilepsy 57
Reflex myoclonic epilepsy in infancy: a critical review 57
Electroclinical features of epilepsy monosomy 1p36 syndrome and their implications 57
The role of polytherapy in the management of epilepsy: suggestions for rational antiepileptic drug selection 57
Refractory absence epilepsy and glut1 deficiency syndrome: a new case report and literature review 56
Epileptic phenotypes in children with early-onset mitochondrial diseases 56
Inflammation in pediatric epilepsies: Update on clinical features and treatment options 55
Perampanel effectiveness and tolerability in patients with epilepsy at long-term follow-up 55
The dilemma of adult-onset Rasmussen encephalitis clinical assessment: Proposal for a new bedside tool to evaluate disease progression 55
Pharmacokinetic considerations for anti-epileptic drugs in children 55
The Ketogenic Diet for the Treatment of Mood Disorders in Comorbidity With Epilepsy in Children and Adolescents 54
Electroclinical findings and long-term outcomes in epileptic patients with inv dup (15) 54
Neuropsychological impairment in childhood absence epilepsy: Review of the literature 53
Relapse risk factors in anti-N-methyl-D-aspartate receptor encephalitis 53
Ketogenic dietary therapies in epilepsy: recommendations of the Italian League against Epilepsy Dietary Therapy Study Group 52
Epileptic phenotypes in autoimmune encephalitis: from acute symptomatic seizures to autoimmune-associated epilepsy 52
Ketogenic diet for super-refractory status epilepticus (SRSE) with NORSE and FIRES: Single tertiary center experience and literature data 51
Understanding Childhood Neuroimmune Diseases of the Central Nervous System 50
Autoantibodies, Encephalopathies, and Epilepsy 46
What are the challenges with the pharmacological management of epilepsy in patients with Attention Deficit Hyperactivity Disorder (ADHD)? 43
Febrile Infection-Related Epilepsy Syndrome (FIRES) 23
EEG abnormalities in a 3-year-old child with developmental delay and autistic-like behavior: a case of Phelan-McDermid syndrome. 9
Fenfluramine treatment for Dravet syndrome: Long term real-world analysis demonstrates safety and reduced health care burden. 9
Immune Epilepsies Study Group of the Italian League Against Epilepsy. Predicting epilepsy after new onset refractory status epilepticus due to autoimmune encephalitis: The DAME score. 7
Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective study. 7
Effectiveness and safety of perampanel by concomitant antiseizure medications: Insights from the real-world PERMIT Extension study. 7
Infantile epileptic spasms syndrome: When spasms come out of the blue. 6
Is highly purified cannabidiol a treatment opportunity for drug-resistant epilepsy in subjects with typical Rett syndrome and CDKL5 deficiency disorder? 5
Expanding the therapeutic role of highly purified cannabidiol in monogenic epilepsies: A multicenter real-world study. 4
Totale 6.781
Categoria #
all - tutte 32.874
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.874


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202229 0 0 0 2 4 0 0 6 1 1 5 10
2022/2023358 10 19 8 5 5 20 9 2 32 203 28 17
2023/2024497 33 21 42 20 34 113 119 27 5 9 11 63
2024/20251.565 87 299 185 43 47 66 54 49 196 117 133 289
2025/20263.523 333 294 351 478 245 123 497 185 396 317 236 68
2026/2027503 92 271 140 0 0 0 0 0 0 0 0 0
Totale 6.781